This webinar will provide an overview of Sentinel’s growing capabilities and value in regulatory decision-making. Sentinel enhances the FDA’s ability to proactively monitor the safety of medical products after they have reached the market and complements the Agency’s existing spontaneous reporting systems. Particular focus will be on Sentinel's role in safety surveillance and use of real-world data (RWD) and real-world evidence (RWE). The webinar will also highlight the efforts and objectives of a patient representative-led stakeholder engagement work group that developed tailored messages for diverse audiences on the broadened uses of Sentinel. Attendees will be invited to offer their suggestions as to how Patient Advocacy Groups may engage more proactively with FDA and particularly Sentinel. Register here.